Our review entitled “New Insights in the Era of Clinical Biomarkers as Potential Predictors of Systemic Therapy-Induced Cardiotoxicity in Women with Breast Cancer: A Systematic Review ” was published in Cancers journal. The aim of the systematic review is to provide an overview of the human studies, which explore novel insights into traditional biomarkers and/or novel biomarkers that can be used for the early detection and/or prediction of CTRCD in breast cancer patients undergoing cardiotoxic-cancer therapies.

CARDIOCARE achieves exciting progress: Two papers accepted for EMBC 2025
We are thrilled to share that two of our innovative papers have been accepted for presentation at the 47th Annual International Conference of the IEEE Engineering in Medicine and Biology Society, to be held in Bella Center, Copenhagen, Denmark, July 14-17, 2025.. This...